Searched for
VIRAL LOAD REDUCTION
‘If Indians stop buying gold for one year, how much would India benefit?’ User asks billion-dollar question to AI, the reply will shock youIndia Gold Buying: A viral X post questioning the economic impact of India's gold obsession sparked a national debate. With gold imports so...- Over 20% Covid-infected people taking Paxlovid experience viral rebound: StudyA study by researchers at Mass General Brigham hospital in Boston found that one in five COVID-infected individuals treated with antiviral ...
- Why do some people who take Paxlovid for Covid get 'rebound' symptoms or test positive again?In a clinical trial, Paxlovid showed an 89% reduction in the risk of hospitalisation and death.
- 'Glenmark's nasal spray can cut covid viral load by 99%
- Covaxin booster dose enhances vaccine effectiveness against Delta, Omicron variants, says ICMR studyThe protective efficacy of Bharat Biotech's Covaxin following two and three-dose immuniszations against the Delta variant and the efficacy ...
- Glenmark to sell nasal spray for Covid care for ₹850On Wednesday, Glenmark and its partner Canada-based SaNOtize Research & Development Corp announced the launch of NONS under the brand name ...
- Omicron viral load at its highest on Day 5? A scientific understanding of the isolation periodSome argue that Omicron is 'mild', but this wave is sweeping through a population.
- Optimus Pharma to launch COVID-19 drug Molnupiravir shortlyThe firm has developed the API (active pharmaceutical ingredient) in house at its R&D centre here. Optimus Pharma has revealed highly promi...
- Pfizer says antiviral pill cut hospitalisation by 89%, neutralised Omicron in lab testsThe company said the 88% efficacy in patients treated within five days of symptom onset, was an increase from the 85% observed in the inter...
- Synthetic SARS-CoV-2 could be used as antiviral therapy for COVID-19: StudyThe cell is then tricked into reproducing the virus's genetic material and packaging it into virions, particles which burst from the cell a...
- Oxford University explores anti-parasitic drug ivermectin as COVID-19 treatmentIvermectin resulted in a reduction of virus replication in laboratory studies, the university said, adding that a small pilot showed giving...
- Oral Covid treatment yields promising trial data: DrugmakersIn January, Merck halted work on two Covid vaccine candidates but has pressed on with research into two products to treat the disease, incl...
- COVID-19: Randomised clinical trial on efficacy of Siddha medicine completedNine other clinical trials involving Siddha medicine either as stand-alone or adjunct with allopathic medicine that were taken up throughou...
- Indian scientists find higher viral load in asymptomatic COVID-19 patientsThe researchers, including those from the Centre for DNA Fingerprinting and Diagnostics (CDFD) in Hyderabad, advise testing asymptomatic pr...
- Glenmark launches Favipiravir: Medics say 'no magic bullet' for COVID but will help amid rising cases"This drug was already being used in Japan for influenza. They have been using it in COVID-19 patients also. Even China was using it and Ru...
- Will the launch of Favipiravir mark the turnaround for Glenmark Pharma?If the drug proves to be efficacious for Covid treatment, Glenmark will cash in on first mover advantage.
- Glenmark Pharma surges 35%, sees biggest intraday rise in history on Covid-19 drug launchThe firm launched antiviral drug Favipiravir for the treatment of Covid-19 patients.
- Over 50 Covid-19 candidates under clinical trials in IndiaOver 50 clinical trials for a Covid-19 vaccine have started in India as researchers globally look for ways to stop the ravaging pandemic.
- Indian scientists develop breakthrough dengue drugxperts are now gearing up for the next step, which is to hold clinical trials and toxicity studies before seeking permission from the Minis...
- Potential biomarker may predict HIV vaccine efficacySt George's, University of London is collaborating with Bionor Pharma to study HIV-associated immune activation that drives disease progres...
Load More
